Equities

Kingworld Medicines Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Kingworld Medicines Group Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)0.495
  • Today's Change-0.005 / -1.00%
  • Shares traded472.00k
  • 1 Year change+20.73%
  • Beta0.7357
Data delayed at least 15 minutes, as of Mar 05 2026 05:38 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kingworld Medicines Group Ltd is an investment holding company primarily engaged in the distribution sale of branded imported pharmaceutical and healthcare products. The Company operates its business through two segments. The Distribution Sales of Pharmaceutical and Health Care Products segment is engaged in the distribution and sales of branded imported pharmaceutical and healthcare products. The distribution products include Nin Jiom Pei Pa Koa, Taiko Seirogan, Foci Kingworld An Gong Niu Huang Wan and other products. The Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices segment is engaged in the manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices. The medical devices and equipment products include infrared thermometers, handheld electrophysical therapeutic products and other products. The Company operates its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)1.07bn
  • Net income in HKD6.17m
  • Incorporated2008
  • Employees759.00
  • Location
    Kingworld Medicines Group Ltd10F, Block A, Tian An International BldgRenmin South RoadLuohu DistrictSHENZHEN 518016ChinaCHN
  • Phone+86 75 582292888
  • Fax+86 75 582170669
  • Websitehttps://www.kingworld.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.